Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib lung tissue distribution in fibrotic interstitial lung disease explants
NL-OMON21428Recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nintedanib in pulmonary fibrosis (PF), sponsored by Erasmus MC. Primary endpoint: Penetration rate of nintedanib in different types of lung tissue. Started Aug 2020; status: recruiting.
02
Drugs
nintedanib
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NL-OMON21428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21428.